[1]
Khawaja, M. et al. 2025. Beneficial effects of SGLT2 Inhibitors on Fatty Liver in Type 2 Diabetes Mellitus. Indus Journal of Bioscience Research. 3, 7 (Jul. 2025), 745–749. DOI:https://doi.org/10.70749/ijbr.v3i7.2075.